Propionic Acid and Fasudil as Treatment Against Rotenone Toxicity in an In Vitro Model of Parkinson's Disease
Parkinson's disease (PD) is a multifactorial neurodegenerative disease. In recent years, several studies demonstrated that the gastroenteric system and intestinal microbiome influence central nervous system function. The pathological mechanisms triggered thereby change neuronal function in neur...
Saved in:
Published in | Molecules (Basel, Switzerland) Vol. 25; no. 11; p. 2502 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI
28.05.2020
MDPI AG |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Parkinson's disease (PD) is a multifactorial neurodegenerative disease. In recent years, several studies demonstrated that the gastroenteric system and intestinal microbiome influence central nervous system function. The pathological mechanisms triggered thereby change neuronal function in neurodegenerative diseases including dopaminergic neurons in Parkinson´s disease. In this study, we employed a model system for PD of cultured primary mesencephalic cells and used the pesticide rotenone to model dopaminergic cell damage. We examined neuroprotective effects of the Rho kinase inhibitor Fasudil and the short chain fatty acid (SCFA) propionic acid on primary neurons in cell morphological assays, cell survival, gene and protein expression. Fasudil application resulted in significantly enhanced neuritic outgrowth and increased cell survival of dopaminergic cells. The application of propionic acid primarily promoted cell survival of dopaminergic cells against rotenone toxicity and increased neurite outgrowth to a moderate extent. Interestingly, Fasudil augmented gene expression of synaptophysin whereas gene expression levels of tyrosine hydroxylase (TH) were substantially increased by propionic acid. Concerning protein expression propionic acid treatment increased STAT3 levels but did not lead to an increased phosphorylation indicative of pathway activation. Our findings indicate that both Fasudil and propionic acid treatment show beneficial potential in rotenone-lesioned primary mesencephalic cells. |
---|---|
AbstractList | Parkinson's disease (PD) is a multifactorial neurodegenerative disease. In recent years, several studies demonstrated that the gastroenteric system and intestinal microbiome influence central nervous system function. The pathological mechanisms triggered thereby change neuronal function in neurodegenerative diseases including dopaminergic neurons in Parkinson´s disease. In this study, we employed a model system for PD of cultured primary mesencephalic cells and used the pesticide rotenone to model dopaminergic cell damage. We examined neuroprotective effects of the Rho kinase inhibitor Fasudil and the short chain fatty acid (SCFA) propionic acid on primary neurons in cell morphological assays, cell survival, gene and protein expression. Fasudil application resulted in significantly enhanced neuritic outgrowth and increased cell survival of dopaminergic cells. The application of propionic acid primarily promoted cell survival of dopaminergic cells against rotenone toxicity and increased neurite outgrowth to a moderate extent. Interestingly, Fasudil augmented gene expression of synaptophysin whereas gene expression levels of tyrosine hydroxylase (TH) were substantially increased by propionic acid. Concerning protein expression propionic acid treatment increased STAT3 levels but did not lead to an increased phosphorylation indicative of pathway activation. Our findings indicate that both Fasudil and propionic acid treatment show beneficial potential in rotenone-lesioned primary mesencephalic cells. |
Author | Ostendorf, Friederike Gold, Ralf Haghikia, Aiden Metzdorf, Judith Tönges, Lars |
AuthorAffiliation | 1 Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, 44791 Bochum, Germany; friederike.ostendorf@rub.de (F.O.); judith.metzdorf@rub.de (J.M.); ralf.gold@rub.de (R.G.); aiden.haghikia@rub.de (A.H.) 2 Neurodegeneration Research, Centre for Protein Diagnostics (ProDi), Ruhr University, 44801 Bochum, Germany |
AuthorAffiliation_xml | – name: 2 Neurodegeneration Research, Centre for Protein Diagnostics (ProDi), Ruhr University, 44801 Bochum, Germany – name: 1 Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, 44791 Bochum, Germany; friederike.ostendorf@rub.de (F.O.); judith.metzdorf@rub.de (J.M.); ralf.gold@rub.de (R.G.); aiden.haghikia@rub.de (A.H.) |
Author_xml | – sequence: 1 givenname: Friederike surname: Ostendorf fullname: Ostendorf, Friederike organization: Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, 44791 Bochum, Germany – sequence: 2 givenname: Judith surname: Metzdorf fullname: Metzdorf, Judith organization: Neurodegeneration Research, Centre for Protein Diagnostics (ProDi), Ruhr University, 44801 Bochum, Germany – sequence: 3 givenname: Ralf surname: Gold fullname: Gold, Ralf organization: Neurodegeneration Research, Centre for Protein Diagnostics (ProDi), Ruhr University, 44801 Bochum, Germany – sequence: 4 givenname: Aiden surname: Haghikia fullname: Haghikia, Aiden organization: Neurodegeneration Research, Centre for Protein Diagnostics (ProDi), Ruhr University, 44801 Bochum, Germany – sequence: 5 givenname: Lars orcidid: 0000-0001-6621-144X surname: Tönges fullname: Tönges, Lars organization: Neurodegeneration Research, Centre for Protein Diagnostics (ProDi), Ruhr University, 44801 Bochum, Germany |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32481507$$D View this record in MEDLINE/PubMed |
BookMark | eNplkU1v1DAQhi3Uin7AD-CCfOO04LGdOL4grVoKK7WiQgvXaGJPFpfEXtlZRP89aReqVj2NNdbz-JXfE3YQUyTG3oB4r5QVH8Y0kNsNVGQFICshX7Bj0FIslND24NH5iJ2UciOEBA3VS3akpG6gEuaYjdc5bUOKwfGlC55j9PwCy86HgWPh60w4jRQnvtxgiGXi39JEdzH4Ov0JLky3PMSZ4qvIf4QpJ36VPA089fwa868ZSfFd4eehEBZ6xQ57HAq9_jdP2feLT-uzL4vLr59XZ8vLhdN1NS20NYCdQbCkGlNbX_e1xk70tbDCaWyM9b7Tjaor21srCaSF2qJoKtN5D-qUrfZen_Cm3eYwYr5tE4b2fpHypsU8BTdQSzVJazrnnCBNlhrfm0aCa1Ql5xxudn3cu7a7biTv5s_IODyRPr2J4We7Sb9boyQAqFkAe4HLqZRM_QMLor3rsX3W48y8ffzoA_G_OPUXKC2eRA |
CitedBy_id | crossref_primary_10_1016_j_trsl_2022_06_003 crossref_primary_10_3389_fnagi_2022_986127 crossref_primary_10_3934_bioeng_2021021 crossref_primary_10_4103_1673_5374_308089 crossref_primary_10_1002_mds_29803 crossref_primary_10_1016_j_heliyon_2024_e26377 crossref_primary_10_1007_s12035_024_04038_2 crossref_primary_10_1186_s12883_021_02544_7 crossref_primary_10_1080_10408398_2023_2272769 crossref_primary_10_3390_cells10040931 crossref_primary_10_1016_j_mce_2022_111572 crossref_primary_10_3390_ijms232012289 crossref_primary_10_1021_acsomega_3c04277 crossref_primary_10_1111_ene_15848 crossref_primary_10_1016_j_celrep_2024_113865 crossref_primary_10_1002_mds_29063 crossref_primary_10_1016_j_arr_2022_101759 crossref_primary_10_1186_s12929_022_00839_6 crossref_primary_10_1002_eng2_12858 crossref_primary_10_1016_j_ejphar_2022_174974 crossref_primary_10_1016_j_biopha_2021_111661 crossref_primary_10_1097_MD_0000000000037960 crossref_primary_10_1038_s41531_023_00554_5 crossref_primary_10_1007_s12264_023_01123_9 crossref_primary_10_1016_j_actbio_2021_03_071 crossref_primary_10_1093_brain_awab156 |
Cites_doi | 10.3390/nu3100858 10.1111/jnc.14928 10.1016/j.stem.2018.06.015 10.1523/JNEUROSCI.0535-12.2012 10.1007/s12017-015-8374-6 10.1186/s40478-016-0310-y 10.1523/JNEUROSCI.23-34-10756.2003 10.1093/brain/aws254 10.1007/s12640-018-9931-1 10.1038/s41598-019-45348-z 10.1016/j.pharmthera.2015.11.012 10.3389/fneur.2019.01245 10.1002/mds.27304 10.5114/fn.2015.54426 10.1111/j.1600-079X.2007.00510.x 10.1186/s40168-018-0439-y 10.1016/j.cell.2016.11.018 10.1016/j.bbr.2006.07.025 10.1016/j.parkreldis.2016.08.019 10.1523/JNEUROSCI.20-09-03214.2000 10.1016/S0924-977X(99)00063-2 10.1016/j.neuropharm.2008.01.013 10.1074/jbc.M210432200 10.1016/j.jns.2015.03.022 10.1016/j.cell.2020.02.035 10.1126/science.6823561 10.1016/j.pharmthera.2018.03.008 10.1002/ana.20904 10.1523/JNEUROSCI.1359-19.2019 10.1097/00004836-200603000-00015 10.1371/journal.pone.0103740 10.1016/j.toxlet.2014.11.029 10.1111/j.1742-4658.2007.06004.x 10.1111/j.1365-2990.2007.00874.x 10.1111/j.1468-1331.2008.02056.x 10.1016/S0140-6736(14)61393-3 10.1038/s41582-020-0344-4 10.1002/mds.26605 10.3389/fendo.2020.00025 10.1523/JNEUROSCI.0096-06.2006 10.1016/j.neuint.2016.02.014 10.2165/00023210-200216100-00004 10.1371/journal.pone.0162696 10.1038/nrneurol.2015.197 10.1016/j.neuint.2018.10.015 10.1523/JNEUROSCI.22-20-08797.2002 10.1517/13543784.17.2.169 10.1101/cshperspect.a033118 10.1002/mds.28016 10.1002/mds.26069 10.1007/s12035-016-0249-9 10.1016/S0197-4580(02)00065-9 |
ContentType | Journal Article |
Copyright | 2020 by the authors. 2020 |
Copyright_xml | – notice: 2020 by the authors. 2020 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 5PM DOA |
DOI | 10.3390/molecules25112502 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1420-3049 |
ExternalDocumentID | oai_doaj_org_article_e6e297bccc0e4e9e8df7821c8352497c 10_3390_molecules25112502 32481507 |
Genre | Journal Article |
GroupedDBID | --- 0R~ 123 2WC 3V. 53G 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ A8Z AADQD AAFWJ AAHBH ABDBF ABJCF ABUWG ACGFO ACIWK ACPRK AEGXH AENEX AFKRA AFPKN AFRAH AFZYC AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS BBNVY BENPR BHPHI BPHCQ BVXVI CCPQU CGR CS3 CUY CVF D1I DIK DU5 E3Z EBD ECM EIF EMOBN ESTFP ESX FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE HZ~ I09 KB. KQ8 LK8 M1P M7P MODMG M~E NPM O-U O9- OK1 P2P PDBOC PIMPY PQQKQ PROAC PSQYO RIG RPM SV3 TR2 TUS UKHRP ~8M AAYXX CITATION 5PM |
ID | FETCH-LOGICAL-c465t-4971ab7a19e38769d6f64ab0f6090c4a879ddb483659f992e129169a0857bdd13 |
IEDL.DBID | RPM |
ISSN | 1420-3049 |
IngestDate | Tue Oct 22 14:49:24 EDT 2024 Tue Sep 17 20:39:15 EDT 2024 Fri Aug 23 04:59:02 EDT 2024 Tue Aug 27 13:46:47 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | neurodegeneration rotenone rho kinase Parkinson’s disease short chain fatty acids |
Language | English |
License | Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c465t-4971ab7a19e38769d6f64ab0f6090c4a879ddb483659f992e129169a0857bdd13 |
ORCID | 0000-0001-6621-144X |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321113/ |
PMID | 32481507 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_e6e297bccc0e4e9e8df7821c8352497c pubmedcentral_primary_oai_pubmedcentral_nih_gov_7321113 crossref_primary_10_3390_molecules25112502 pubmed_primary_32481507 |
PublicationCentury | 2000 |
PublicationDate | 20200528 |
PublicationDateYYYYMMDD | 2020-05-28 |
PublicationDate_xml | – month: 5 year: 2020 text: 20200528 day: 28 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Molecules (Basel, Switzerland) |
PublicationTitleAlternate | Molecules |
PublicationYear | 2020 |
Publisher | MDPI MDPI AG |
Publisher_xml | – name: MDPI – name: MDPI AG |
References | Adler (ref_4) 2016; 31 Silva (ref_22) 2020; 11 (ref_40) 2015; 5 Unger (ref_11) 2016; 32 Jackson (ref_21) 2019; 10 Abdelli (ref_53) 2019; 9 Li (ref_26) 2002; 278 Hawkes (ref_8) 2007; 33 Radad (ref_28) 2015; 3 ref_52 Daihan (ref_14) 2015; 4 Kalia (ref_5) 2015; 386 Liu (ref_49) 2016; 54 Langston (ref_17) 1983; 219 Erkkinen (ref_1) 2017; 10 Cabin (ref_39) 2002; 22 Langston (ref_16) 2017; 7 Lin (ref_31) 2008; 44 Wong (ref_12) 2006; 40 Ghaisas (ref_13) 2015; 158 Leng (ref_37) 2006; 26 Vinolo (ref_51) 2011; 3 Frank (ref_25) 2012; 135 Sadler (ref_46) 2019; 40 Klingelhoefer (ref_2) 2015; 11 Perucca (ref_45) 2002; 16 Hahnen (ref_44) 2008; 17 Koch (ref_24) 2018; 189 Zhao (ref_29) 2015; 353 Sampson (ref_10) 2016; 167 Macfabe (ref_54) 2007; 176 Ascherio (ref_20) 2006; 60 Lei (ref_43) 2016; 95 ref_36 ref_33 ref_30 Srivastava (ref_32) 2007; 274 Sherer (ref_18) 2003; 23 Yuan (ref_19) 2015; 233 Bonnet (ref_23) 2000; 10 Duscha (ref_47) 2020; 180 Sommer (ref_50) 2018; 23 Poewe (ref_3) 2008; 15 Mulak (ref_9) 2018; 33 Scheperjans (ref_7) 2014; 30 Tatenhorst (ref_42) 2016; 4 Shultz (ref_55) 2008; 54 Mouhape (ref_27) 2018; 35 Braak (ref_6) 2003; 24 Scott (ref_41) 2012; 32 Hoyles (ref_15) 2018; 6 Trujillo (ref_34) 2018; 121 ref_48 Chen (ref_35) 2015; 17 Murphy (ref_38) 2000; 20 |
References_xml | – volume: 3 start-page: 858 year: 2011 ident: ref_51 article-title: Regulation of Inflammation by Short Chain Fatty Acids publication-title: Nutrients doi: 10.3390/nu3100858 contributor: fullname: Vinolo – ident: ref_30 doi: 10.1111/jnc.14928 – volume: 23 start-page: 123 year: 2018 ident: ref_50 article-title: Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson’s Disease publication-title: Cell Stem Cell doi: 10.1016/j.stem.2018.06.015 contributor: fullname: Sommer – volume: 32 start-page: 10129 year: 2012 ident: ref_41 article-title: α-Synuclein inhibits intersynaptic vesicle mobility and maintains recycling-pool homeostasis publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.0535-12.2012 contributor: fullname: Scott – volume: 17 start-page: 454 year: 2015 ident: ref_35 article-title: Role of Rho Kinase and Fasudil on Synaptic Plasticity in Multiple Sclerosis publication-title: NeuroMol. Med. doi: 10.1007/s12017-015-8374-6 contributor: fullname: Chen – volume: 4 start-page: 39 year: 2016 ident: ref_42 article-title: Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease publication-title: Acta Neuropathol. Commun. doi: 10.1186/s40478-016-0310-y contributor: fullname: Tatenhorst – volume: 23 start-page: 10756 year: 2003 ident: ref_18 article-title: Mechanism of Toxicity in Rotenone Models of Parkinson’s Disease publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.23-34-10756.2003 contributor: fullname: Sherer – volume: 135 start-page: 3355 year: 2012 ident: ref_25 article-title: Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson’s disease publication-title: Brain doi: 10.1093/brain/aws254 contributor: fullname: Frank – volume: 35 start-page: 71 year: 2018 ident: ref_27 article-title: Nicotine-Induced Neuroprotection in Rotenone In Vivo and In Vitro Models of Parkinson’s Disease: Evidences for the Involvement of the Labile Iron Pool Level as the Underlying Mechanism publication-title: Neurotox. Res. doi: 10.1007/s12640-018-9931-1 contributor: fullname: Mouhape – volume: 9 start-page: 8824 year: 2019 ident: ref_53 article-title: Propionic Acid Induces Gliosis and Neuro-inflammation through Modulation of PTEN/AKT Pathway in Autism Spectrum Disorder publication-title: Sci. Rep. doi: 10.1038/s41598-019-45348-z contributor: fullname: Abdelli – volume: 158 start-page: 52 year: 2015 ident: ref_13 article-title: Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases publication-title: Pharmacol. Ther. doi: 10.1016/j.pharmthera.2015.11.012 contributor: fullname: Ghaisas – volume: 10 start-page: 1245 year: 2019 ident: ref_21 article-title: Diet in Parkinson’s Disease: Critical Role for the Microbiome publication-title: Front. Neurol. doi: 10.3389/fneur.2019.01245 contributor: fullname: Jackson – volume: 33 start-page: 398 year: 2018 ident: ref_9 article-title: A controversy on the role of short-chain fatty acids in the pathogenesis of Parkinson’s disease publication-title: Mov. Disord. doi: 10.1002/mds.27304 contributor: fullname: Mulak – volume: 3 start-page: 250 year: 2015 ident: ref_28 article-title: Rapamycin protects dopaminergic neurons against rotenone-induced cell death in primary mesencephalic cell culture publication-title: Folia Neuropathol. doi: 10.5114/fn.2015.54426 contributor: fullname: Radad – volume: 44 start-page: 205 year: 2008 ident: ref_31 article-title: Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats publication-title: J. Pineal Res. doi: 10.1111/j.1600-079X.2007.00510.x contributor: fullname: Lin – volume: 6 start-page: 55 year: 2018 ident: ref_15 article-title: Microbiome-host systems interactions: Protective effects of propionate upon the blood–brain barrier publication-title: Microbiome doi: 10.1186/s40168-018-0439-y contributor: fullname: Hoyles – volume: 7 start-page: S11 year: 2017 ident: ref_16 article-title: The MPTP Story publication-title: J. Park. Dis. contributor: fullname: Langston – volume: 167 start-page: 1469 year: 2016 ident: ref_10 article-title: Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease publication-title: Cell doi: 10.1016/j.cell.2016.11.018 contributor: fullname: Sampson – volume: 176 start-page: 149 year: 2007 ident: ref_54 article-title: Neurobiological effects of intraventricular propionic acid in rats: Possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders publication-title: Behav. Brain Res. doi: 10.1016/j.bbr.2006.07.025 contributor: fullname: Macfabe – volume: 32 start-page: 66 year: 2016 ident: ref_11 article-title: Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls publication-title: Park. Relat. Disord. doi: 10.1016/j.parkreldis.2016.08.019 contributor: fullname: Unger – volume: 20 start-page: 3214 year: 2000 ident: ref_38 article-title: Synucleins Are Developmentally Expressed, and α-Synuclein Regulates the Size of the Presynaptic Vesicular Pool in Primary Hippocampal Neurons publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.20-09-03214.2000 contributor: fullname: Murphy – volume: 10 start-page: 97 year: 2000 ident: ref_23 article-title: Intracellular pH modulates spontaneous and epileptiform bioelectric activity of hippocampal CA3-neurones publication-title: Eur. Neuropsychopharmacol. doi: 10.1016/S0924-977X(99)00063-2 contributor: fullname: Bonnet – volume: 54 start-page: 901 year: 2008 ident: ref_55 article-title: Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: Implications for an animal model of autism publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2008.01.013 contributor: fullname: Shultz – volume: 278 start-page: 8516 year: 2002 ident: ref_26 article-title: Mitochondrial Complex I Inhibitor Rotenone Induces Apoptosis through Enhancing Mitochondrial Reactive Oxygen Species Production publication-title: J. Boil. Chem. doi: 10.1074/jbc.M210432200 contributor: fullname: Li – volume: 353 start-page: 28 year: 2015 ident: ref_29 article-title: Multitarget intervention of Fasudil in the neuroprotection of dopaminergic neurons in MPTP-mouse model of Parkinson’s disease publication-title: J. Neurol. Sci. doi: 10.1016/j.jns.2015.03.022 contributor: fullname: Zhao – volume: 180 start-page: 1067 year: 2020 ident: ref_47 article-title: Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism publication-title: Cell doi: 10.1016/j.cell.2020.02.035 contributor: fullname: Duscha – volume: 4 start-page: 188 year: 2015 ident: ref_14 article-title: Impact of Propionic Acid on Liver Damage in Rats publication-title: Int. J. Mol. Cell. Med. contributor: fullname: Daihan – volume: 219 start-page: 979 year: 1983 ident: ref_17 article-title: Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis publication-title: Science doi: 10.1126/science.6823561 contributor: fullname: Langston – volume: 189 start-page: 1 year: 2018 ident: ref_24 article-title: ROCK inhibition in models of neurodegeneration and its potential for clinical translation publication-title: Pharmacol. Ther. doi: 10.1016/j.pharmthera.2018.03.008 contributor: fullname: Koch – volume: 60 start-page: 197 year: 2006 ident: ref_20 article-title: Pesticide exposure and risk for Parkinson’s disease publication-title: Ann. Neurol. doi: 10.1002/ana.20904 contributor: fullname: Ascherio – volume: 40 start-page: 1162 year: 2019 ident: ref_46 article-title: Short-Chain Fatty Acids Improve Poststroke Recovery via Immunological Mechanisms publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.1359-19.2019 contributor: fullname: Sadler – volume: 40 start-page: 235 year: 2006 ident: ref_12 article-title: Colonic Health: Fermentation and Short Chain Fatty Acids publication-title: J. Clin. Gastroenterol. doi: 10.1097/00004836-200603000-00015 contributor: fullname: Wong – ident: ref_36 doi: 10.1371/journal.pone.0103740 – volume: 233 start-page: 163 year: 2015 ident: ref_19 article-title: The molecular mechanism of rotenone-induced α-synuclein aggregation: Emphasizing the role of the calcium/GSK3β pathway publication-title: Toxicol. Lett. doi: 10.1016/j.toxlet.2014.11.029 contributor: fullname: Yuan – volume: 274 start-page: 4788 year: 2007 ident: ref_32 article-title: Rotenone inhibits mammalian cell proliferation by inhibiting microtubule assembly through tubulin binding publication-title: FEBS J. doi: 10.1111/j.1742-4658.2007.06004.x contributor: fullname: Srivastava – volume: 33 start-page: 599 year: 2007 ident: ref_8 article-title: Parkinson’s disease: A dual-hit hypothesis publication-title: Neuropathol. Appl. Neurobiol. doi: 10.1111/j.1365-2990.2007.00874.x contributor: fullname: Hawkes – volume: 5 start-page: 699 year: 2015 ident: ref_40 article-title: The Synaptic Function of α-Synuclein publication-title: J. Park. Dis. – volume: 15 start-page: 14 year: 2008 ident: ref_3 article-title: Non-motor symptoms in Parkinson’s disease publication-title: Eur. J. Neurol. doi: 10.1111/j.1468-1331.2008.02056.x contributor: fullname: Poewe – volume: 386 start-page: 896 year: 2015 ident: ref_5 article-title: Parkinson’s disease publication-title: Lancet doi: 10.1016/S0140-6736(14)61393-3 contributor: fullname: Kalia – ident: ref_48 doi: 10.1038/s41582-020-0344-4 – volume: 31 start-page: 1114 year: 2016 ident: ref_4 article-title: Neuropathological basis of nonmotor manifestations of Parkinson’s disease publication-title: Mov. Disord. doi: 10.1002/mds.26605 contributor: fullname: Adler – volume: 11 start-page: 25 year: 2020 ident: ref_22 article-title: The Role of Short-Chain Fatty Acids from Gut Microbiota in Gut-Brain Communication publication-title: Front. Endocrinol. doi: 10.3389/fendo.2020.00025 contributor: fullname: Silva – volume: 26 start-page: 7502 year: 2006 ident: ref_37 article-title: Endogenous α-Synuclein Is Induced by Valproic Acid through Histone Deacetylase Inhibition and Participates in Neuroprotection against Glutamate-Induced Excitotoxicity publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.0096-06.2006 contributor: fullname: Leng – volume: 95 start-page: 75 year: 2016 ident: ref_43 article-title: Fatty acids and their therapeutic potential in neurological disorders publication-title: Neurochem. Int. doi: 10.1016/j.neuint.2016.02.014 contributor: fullname: Lei – volume: 16 start-page: 695 year: 2002 ident: ref_45 article-title: Pharmacological and Therapeutic Properties of Valproate publication-title: CNS Drugs doi: 10.2165/00023210-200216100-00004 contributor: fullname: Perucca – ident: ref_33 doi: 10.1371/journal.pone.0162696 – volume: 11 start-page: 625 year: 2015 ident: ref_2 article-title: Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors publication-title: Nat. Rev. Neurol. doi: 10.1038/nrneurol.2015.197 contributor: fullname: Klingelhoefer – volume: 121 start-page: 26 year: 2018 ident: ref_34 article-title: Docosahexaenoic acid protection in a rotenone induced Parkinson’s model: Prevention of tubulin and synaptophysin loss, but no association with mitochondrial function publication-title: Neurochem. Int. doi: 10.1016/j.neuint.2018.10.015 contributor: fullname: Trujillo – volume: 22 start-page: 8797 year: 2002 ident: ref_39 article-title: Synaptic Vesicle Depletion Correlates with Attenuated Synaptic Responses to Prolonged Repetitive Stimulation in Mice Lacking α-Synuclein publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.22-20-08797.2002 contributor: fullname: Cabin – volume: 17 start-page: 169 year: 2008 ident: ref_44 article-title: Histone deacetylase inhibitors: Possible implications for neurodegenerative disorders publication-title: Expert Opin. Investig. Drugs doi: 10.1517/13543784.17.2.169 contributor: fullname: Hahnen – volume: 10 start-page: a033118 year: 2017 ident: ref_1 article-title: Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases publication-title: Cold Spring Harb. Perspect. Biol. doi: 10.1101/cshperspect.a033118 contributor: fullname: Erkkinen – ident: ref_52 doi: 10.1002/mds.28016 – volume: 30 start-page: 350 year: 2014 ident: ref_7 article-title: Gut microbiota are related to Parkinson’s disease and clinical phenotype publication-title: Mov. Disord. doi: 10.1002/mds.26069 contributor: fullname: Scheperjans – volume: 54 start-page: 7762 year: 2016 ident: ref_49 article-title: Th17 Cells Induce Dopaminergic Neuronal Death via LFA-1/ICAM-1 Interaction in a Mouse Model of Parkinson’s Disease publication-title: Mol. Neurobiol. doi: 10.1007/s12035-016-0249-9 contributor: fullname: Liu – volume: 24 start-page: 197 year: 2003 ident: ref_6 article-title: Staging of brain pathology related to sporadic Parkinson’s disease publication-title: Neurobiol. Aging doi: 10.1016/S0197-4580(02)00065-9 contributor: fullname: Braak |
SSID | ssj0021415 |
Score | 2.4803512 |
Snippet | Parkinson's disease (PD) is a multifactorial neurodegenerative disease. In recent years, several studies demonstrated that the gastroenteric system and... Parkinson’s disease (PD) is a multifactorial neurodegenerative disease. In recent years, several studies demonstrated that the gastroenteric system and... |
SourceID | doaj pubmedcentral crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 2502 |
SubjectTerms | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs & derivatives 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - pharmacology 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - therapeutic use Animals Blotting, Western Cell Survival - drug effects Cells, Cultured Dopaminergic Neurons - drug effects Dopaminergic Neurons - metabolism Female Immunohistochemistry neurodegeneration Neuroprotective Agents - pharmacology Neuroprotective Agents - therapeutic use Parkinson Disease - drug therapy Parkinson Disease - metabolism Parkinson’s disease Pregnancy Propionates - pharmacology Propionates - therapeutic use Rats Rats, Sprague-Dawley rho kinase rho-Associated Kinases - metabolism rotenone Rotenone - toxicity short chain fatty acids Tyrosine 3-Monooxygenase - metabolism |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3JbtRAEG1FuYRLRAKEIRDVgROSlW73YvcxhIwCEghFE5Sb1StYCnY0dqQc8xv8Xr6EansmGotDLly9lqrseu_1UkXIex8x5zH8kZAcoEDJg8-MDDbjkkaJhCRSk2Z0v35T55fiy5W82mj1ldaEjeWBR8cdBxVyXVjnHA0i6FD6iKDGXGIOQhduyL5Ur8XUSmoxxKVxDpOjqD_-PbaaDV0i1Aj6-QSFhmL9Gwg0XR25ATfz52R3xRPhZLRvj2yFZp_snK7bs70g7fdle5MGUx2cuNqDaTzMTXfr62swHSzWC8jB_ETx3_Vw0SI9bpsAi_audki-oW7wLvjcwI-6X7aQ2qJdQxsh7YQeNoU93P_p4NM4hfOSXM7PFqfn2ap7QuaEkn1qHceMLQzTgWPK015FJYylUVFNnTBlob23ouRK6qh1HhD5mdImlby33jP-imwnq14TUIXXsTQ8GpULJ6jlTrFglYwsV9HIGfmw9mZ1MxbJqFBcJNdX_7h-Rj4mfz9emOpbDwcw6tUq6tVTUZ-RgzFIj49BYlgmcjsjxSR8k_dMzzT1r6GedsFRBTP-5n8Ydkie5UmRU5nl5Vuy3S9vwzukLb09Gr7Qv7yc72A priority: 102 providerName: Directory of Open Access Journals |
Title | Propionic Acid and Fasudil as Treatment Against Rotenone Toxicity in an In Vitro Model of Parkinson's Disease |
URI | https://www.ncbi.nlm.nih.gov/pubmed/32481507 https://pubmed.ncbi.nlm.nih.gov/PMC7321113 https://doaj.org/article/e6e297bccc0e4e9e8df7821c8352497c |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwEB0BPdBLRaG0W-jKh56QwsZJ7MRH2LKiSKAVWipukT9ppN1ktbtIPfZv8Pf4JYzzgYh66zWJE8cz8bwXj-cBfDcO5zyKHxKCAyQokTWBZFYFMQsdQ0DiQulXdK9v-OVdcnXP7reAdXth6qR9rYrTcr44LYvfdW7lcqFHXZ7YaHo9TuPIK6SPtmEbHbSj6C3LohiSmuXLGPn8aNGozNq1x9IY7718DYKIzAOhXiyqS_a_iUP9HMk3QWeyBx9atEjOml59hC1b7sPuuBNpO4BquqqW_peqJme6MESWhkzk-tEUcyLXZNalkRP5IAtEguS2QpBclZbMqj-FRghOihJbkZ8l-VVsVhXx4mhzUjni90PXW8Oe_z6tyY9mIecT3E0uZuPLoNVQCHTC2cYLyFGpUkmFjXHiE4Y7nkgVOh6KUCcyS4UxKslizoQTIrIY_ykX0he-V8bQ-BB2fK--AOGpES6TsZM8SnQSqlhzahVnjkbcSTaAk24082VTKiNHiuGtkP9jhQGc-_F-vdBXua4PVKuHvLV1brmNRKq01qFNrLCZcQhoqPaoEV9MD-BzY6TX23SWHUDaM1_vOf0z6GR1Ve3Wqb7-d8sjeB95Mh6yIMqOYWezerTfELFs1BDenV_cTG-HNeMf1v76AkLo8Zw |
link.rule.ids | 230,315,730,783,787,867,888,2109,27936,27937,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFL0qZVE2UF5laAEvWCFlJi878bIMjKbQqSo0rbqL_CwRM8loJiMhVvwGv9cv4TqPqoEVbOM4sXNs33Pj63sA3mqLa16AEwnJATooodGeoEZ6EfUtRUJifeF2dGdnbHoRf7qiVztAu7MwddC-kvmwWCyHRf61jq1cLdWoixMbnc_GSRQ6hfTRPbiP89WPOye99bMCNErNBmaEHv1o2ejMmo1j02jxnYAN0ojUUaGeNaqT9t-xRP0oyTtmZ_IILrsGN9Em34bbSg7Vjz9yOf5zj_bhYUtEyXFT_Bh2TPEE9sad_ttTKM_X5cr9rVXkWOWaiEKTidhsdb4gYkPmXYQ6EdciR5JJvpTIv8vCkHn5PVfI7kleYC1yUpDLvFqXxOmuLUhpiTtqXZ86u_n5a0M-NHtEz-Bi8nE-nnqtPIOnYkYrp00XCJmIgJsI11SumWWxkL5lPvdVLNKEay3jNGKUW85Dg9QiYFy4nPpS6yB6DruuVS-AsERzm4rIChbGKvZlpFhgJKM2CJkVdADvOpiyVZOFI0PvxcGb_QXvAN47IG9vdAm06wvl-jprP3pmmAl5IpVSvokNN6m2yJUC5QgpdkwN4KBB__Yx3ZAZQNIbF7339EsQ7Tphd4vuy_-u-Qb2pvPZaXZ6cvb5EB6Ezuf3qRemR7BbrbfmFRKjSr6up8FvlsURBA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSMCFN3R5-sAJKRs7iZ34WLasWqDVCm1RxSXys0TdTVa7WQlx4m_w9_gljPOoNnDrNbETOzP2fJMZz4fQW-Ngz6OwkAAcgIMSWRNIZlUQM-IYABJHpI_onpzyo7Pk4zk736H6apL2tSrG5WI5LovvTW7laqnDPk8snJ1M0jjyDOnhyrjwJroFa5bw3lHvfC0KhqkNYsbg1YfLlmvWbjyiBqvvSWwASmQeDg0sUlO4f8caDTMld0zP9D761g-6zTi5HG9rNdY__6nneK1ZPUD3OkCKD9omD9ENWz5CdyY9D9xjVM3W1cr_tdX4QBcGy9LgqdxsTbHAcoPnfaY6lheyALCJv1SAw6vS4nn1o9CA8nFRQi98XOKvRb2usOdfW-DKYX_kujl99ufX7w0-bGNFT9DZ9MN8chR0NA2BTjirPUcdlSqVVNgY9lZhuOOJVMRxIohOZJYKY1SSxZwJJ0RkAWJQLqSvra-MofFTtOdHtY8wT41wmYyd5FGiE6JizalVnDkacSfZCL3rRZWv2mocOXgxXsT5fyIeofdemFcNfSHt5kK1vsi7D59bbiORKq01sYkVNjMOMBPVHpjCxPQIPWs14OoxvdqMUDrQjcF7hndA4k3h7k7Cz6_d8w26PTuc5p-PTz-9QHcj7_oTFkTZS7RXr7f2FeCjWr1uVsJfDNQThA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Propionic+Acid+and+Fasudil+as+Treatment+against+Rotenone+Toxicity+in+an+In+Vitro+Model+of+Parkinson%E2%80%99s+Disease&rft.jtitle=Molecules+%28Basel%2C+Switzerland%29&rft.au=Ostendorf%2C+Friederike&rft.au=Metzdorf%2C+Judith&rft.au=Gold%2C+Ralf&rft.au=Haghikia%2C+Aiden&rft.date=2020-05-28&rft.pub=MDPI&rft.eissn=1420-3049&rft.volume=25&rft.issue=11&rft_id=info:doi/10.3390%2Fmolecules25112502&rft_id=info%3Apmid%2F32481507&rft.externalDBID=PMC7321113 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-3049&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-3049&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-3049&client=summon |